Myriam Bouchfaa
Papers
1
Total Citations
1
H-Index
1
About
Myriam Bouchfaa is a researcher dedicated to advancing the safety of pharmaceutical compounding, with a primary focus on the handling of hazardous cytotoxic drugs. Her key research area lies in evaluating contamination risks associated with automated systems, particularly robotic compounding technologies designed to prepare cancer medications. In her most cited work, a 2024 pilot study, Bouchfaa conducted a rigorous assessment of chemical contamination by cancer drugs during the use of the RIVA™ compounding robot, examining both internal and external surfaces for traces of cytotoxics. This study provides critical insights into the real-world safety of robotic systems, helping hospitals mitigate occupational exposure risks for healthcare workers. While her citation count is currently emerging, her research addresses a pressing need in oncology pharmacy practice, where the adoption of automation is rapidly increasing. Bouchfaa’s contributions are vital for informing best practices and safety protocols, ensuring that technological advancements in drug compounding do not compromise worker protection. Her work represents an important step toward safer, more efficient pharmaceutical care in cancer treatment settings.
Research Focus
Key Achievements
Top Papers
- 1